The quest for a vaccine could restore faith in big pharma
The boffins of AstraZeneca are showing the way forward
UNPRECEDENTED IS AN overused word. But to find a parallel for the response of the pharmaceutical industry to the covid-19 pandemic, it is necessary to go back to the start of the second world war, another time when countries were desperate for miracle cures. Back then big pharmaceutical companies, especially in America, were as unproductive and unloved as they are today. People were appalled at the mis-selling of addictive narcotics, as they have been during the opioid crisis. And in pre-war Britain, scientists had discovered what they believed could be a wonder antibiotic—penicillin. Yet they could not find any firm, even in America, prepared to take the risk of producing it at scale.
This article appeared in the Business section of the print edition under the headline “Boffins v the bug”
Business
June 6th 2020- The sharing economy will have to change
- Companies are still raising cash by floating
- The video-games industry raids its back catalogue
- Twitter and Facebook have differing business models
- The boss of IKEA on dealing with the fallout of the covid crisis
- A guide for foreign workers at Chinese firms
- The quest for a vaccine could restore faith in big pharma
From the June 6th 2020 edition
Discover stories from this section and more in the list of contents
Explore the edition
How Trump’s tariffs could crush American carmakers
They must hope the levies do not endure
The Economist’s office agony uncle is back
Another bulging postbag for Max Flannel

The smiling new face of German big business
From Allianz to Zalando, pedlars of services are outdoing industrial firms at home—and foreign rivals abroad
Airbus has not taken full advantage of Boeing’s weakness
That could leave a gap for other planemakers to fill
The business of second-hand clothing is booming
Can it be profitable, too?
Zyn is giving investors a buzz—for now
Nicotine pouches are growing fast